PWPS
PCVX icon

Pinnacle Wealth Planning Services’s Vaxcyte PCVX Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.7K Hold
890
– – ﹤0.01% 1255
2026
Q1 		$51.7K Hold
890
– – 0.01% 1185
2025
Q4 		$41.1K Buy
+890
New +$39.8K ﹤0.01% 1338

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Pinnacle Wealth Planning Services's PCVX Position: Q2 2026 in Review

Pinnacle Wealth Planning Services held its Vaxcyte (PCVX) position steady in Q2 2026 at 890 shares worth $51.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1255.

Pinnacle Wealth Planning Services first reported a position in PCVX in Q4 2025 and has held it in 3 quarters since. 332 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Pinnacle Wealth Planning Services held 890 shares of Vaxcyte worth $51.7K as of Q2 2026.
  • Pinnacle Wealth Planning Services left its Vaxcyte share count unchanged in Q2 2026.
  • Vaxcyte made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #1255 holding.
  • Pinnacle Wealth Planning Services first reported a position in Vaxcyte in Q4 2025 and has held it in 3 quarters since.
  • 332 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.